首页 | 本学科首页   官方微博 | 高级检索  
     

NP和MVP方案治疗非小细胞肺癌的初步比较
引用本文:朱建光,潘峰,黄瑞燕,李骏白,周成槎. NP和MVP方案治疗非小细胞肺癌的初步比较[J]. 肿瘤学杂志, 2000, 0(3)
作者姓名:朱建光  潘峰  黄瑞燕  李骏白  周成槎
作者单位:浙江省温州市肿瘤医院!浙江温州325007
摘    要:目的]初步比较NP和MVP方案对晚期非小细胞肺癌(NSCLC)的疗效和不良反应。[方法]45例Ⅲ期或Ⅳ期NSCLC患者随机分为A组和B组 ,A组应用NP(去甲长春花碱 顺铂)方案化疗 ,B组应用MVP(丝裂霉素 长春花碱酰胺 顺铂)方案化疗 ,至少连用2周期后评价疗效和不良反应。[结果]两组均无完全缓解病例 ,A组有效率为45 5 %(10/22) ,B组35 0 %(7/20) ,差异无显著性(P>0 05)。其中对腺癌有效率A组为53 3 %(8/15) ,B组为35 7%(4/14)。A组静脉炎发生率为27 3 %(6/22) ,B组为0(P<0 05) ;其它不良反应两组均相似。[结论]NP方案为治疗晚期NSCLC较为有效和安全的化疗方案。

关 键 词:非小细胞肺癌  药物疗法  去甲长春花碱  长春花碱酰胺  顺铂  丝裂霉素

Comparison of NP and MVP Chemotherapy in Advanced Non-Small Cell Lung Cancer
ZHU Jianguang,PAN Feng,HUANG Ruiyan,et al. Comparison of NP and MVP Chemotherapy in Advanced Non-Small Cell Lung Cancer[J]. Journal of Chinese Oncology, 2000, 0(3)
Authors:ZHU Jianguang  PAN Feng  HUANG Ruiyan  et al
Abstract:To compare the therapeutic effect and side effect between NP regimen and MVP regimen in advanced nonsmall lung cancer(NSCLC)Fortyfive patients with advanced NSCLC were randomized into two groupsThe patients in Group A were treated by NP regimen(navelbine plus cisplatin)and in Group B by MVP regimen(mitomycin C,vindesine plus cisplatin)Patients who completed at least 2 cycles chemotherapy were evaluated.Fortytwo patients were evaluatedCompleted response was not observed in all patients in both groupsThe response rate (RR) in group A was 455%(10/22),350%(7/20) in group B(P>005)For adenocarcinoma,the RR in group A was 533%(8/15),and 357%(4/14) in group BPhlebitis was observed in 273%(6/22) of the patients in group A and zero in group B(P<005)Side effects were similar in both groups[Conclusion]NP regimen is an effective and safe chemotherapy regimen for advanced NSCLC patients
Keywords:nonsmall cell lung cancer  drug therapy  navelbine  vindesine  cisplatin  mitomycin
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号